Tue, August 13, 2024

Matt O"Brien Maintained (TELA) at Buy with Decreased Target to $8 on, Aug 13th, 2024

Matt O"Brien of Piper Sandler, Maintained "TELA Bio, Inc." (TELA) at Buy with Decreased Target from $10 to $8 on, Aug 13th, 2024.

Matt, nor any peers, have made any analyst calls on TELA in the last 4 months.